Laboratory Corporation of America Holdings (NYSE:LH) went up by 0.65% from its latest closing price compared to the recent 1-year high of $317.17. The company’s stock price has collected -2.26% of loss in the last five trading sessions. The Wall Street Journal reported on 07/28/22 that Labcorp to Spin Off Clinical-Development Business
Is It Worth Investing in Laboratory Corporation of America Holdings (NYSE :LH) Right Now?
Laboratory Corporation of America Holdings (NYSE:LH) scored a price-to-earnings ratio above its average ratio, recording 12.72 x from its present earnings ratio. Plus, the 36-month beta value for LH is at 1.07. Opinions of the stock are interesting as 12 analysts out of 17 who provided ratings for Laboratory Corporation of America Holdings declared the stock was a “buy,” while 2 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $278.46, which is $40.4 above the current price. LH currently public float of 88.36M and currently shorts hold a 1.30% ratio of that float. Today, the average trading volume of LH was 768.18K shares.
LH’s Market Performance
LH stocks went down by -2.26% for the week, with a monthly jump of 4.42% and a quarterly performance of 0.52%, while its annual performance rate touched -16.66%. The volatility ratio for the week stands at 3.30% while the volatility levels for the past 30 days are set at 3.05% for Laboratory Corporation of America Holdings. The simple moving average for the period of the last 20 days is 2.41% for LH stocks with a simple moving average of -2.55% for the last 200 days.
Analysts’ Opinion of LH
Morgan Stanley, on the other hand, stated in their research note that they expect to see LH reach a price target of $300. The rating they have provided for LH stocks is “Overweight” according to the report published on August 22nd, 2022.
Deutsche Bank gave a rating of “Hold” to LH, setting the target price at $294 in the report published on January 28th of the current year.
LH Trading at 7.92% from the 50-Day Moving Average
After a stumble in the market that brought LH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.87% of loss for the given period.
Volatility was left at 3.05%, however, over the last 30 days, the volatility rate increased by 3.30%, as shares surge +3.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.88% upper at present.
During the last 5 trading sessions, LH fell by -2.26%, which changed the moving average for the period of 200-days by -14.34% in comparison to the 20-day moving average, which settled at $233.09. In addition, Laboratory Corporation of America Holdings saw -24.16% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at LH starting from Schroeder Mark S, who sale 1,116 shares at the price of $232.67 back on Nov 08. After this action, Schroeder Mark S now owns 6,687 shares of Laboratory Corporation of America Holdings, valued at $259,660 using the latest closing price.
EISENBERG GLENN A, the Chief Financial Officer, EVP of Laboratory Corporation of America Holdings, sale 25,000 shares at $210.62 during a trade that took place back on Sep 26, which means that EISENBERG GLENN A is holding 27,158 shares at $5,265,576 based on the most recent closing price.
Stock Fundamentals for LH
Current profitability levels for the company are sitting at:
- +20.85 for the present operating margin
- +32.60 for the gross margin
The net margin for Laboratory Corporation of America Holdings stands at +14.75. Equity return is now at value 16.90, with 8.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.92.